ADEG(redirected from Antiarrhythmic Drug Evaluation Group Trial)
ADEGAntiarrhythmic Drug Evaluation Group Trial. A trial comparing benefit/risk profiles of flecainide, propafenone, amiodarone in patients with complex ventricular arrhythmias and heart disease.
Conclusion Cardiovascular adverse events were less common with amiodarone; different effects of study drugs on heart rate variability may contribute to mortality.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.